Advertisement
Advertisement

THRD

THRD logo

Third Harmonic Bio Inc

11.73
USD
+0.38
+3.35%
Dec 18, 13:35 UTC -5
Open

Third Harmonic Bio Inc Profile

About

Third Harmonic Bio Inc. is a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for allergy and inflammation. The company's principal candidate includes THB001, is a highly selective, oral small-molecule inhibitor of KIT. Third Harmonic Bio Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Natalie Holles

Headquarters

1700 MONTGOMERY STREET, SUITE 210
SAN FRANCISCO, CA 94111, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

8

Employees

30

Third Harmonic Bio Inc Statistics

Valuation Measures

Market Capitalization2

528.55M

Enterprise Value

232.46M

Enterprise Value/EBITDA(ttm)

-5.05

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-9.31%

Return on Invested Capital(ttm)

-11.84%

Return on Assets(ttm)

-9.03%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-46.08M

Net Income Available to Common(ttm)

-32.90M

Diluted EPS(ttm)

-0.62

Share Statistics

Beta (5Y Monthly)

2.64

52-Week Change

23.47%

S&P 500 52-Week Change

27.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

45.06M

Dividend Yield

0.00%

Float4

42.40M

% Held by Insiders

5.90%

% Held by Institutions

93.95%

Balance Sheet

Total Cash(mrq)

296.09M

Total Cash Per Share(mrq)

6.57

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

42.50%

Quick Ratio(mrq)

42.50%

Book Value Per Share(mrq)

6.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-23.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement